Aktiesnakken — Marts 2020
-
-
Chloroquine use for Covid19 Coronavirus shows no benefit in first small - But limited- controlled trial. https://finance.yahoo.com/news/stock-market-news-live-updates-march-24-2020-221411642.html
-
-
FDA grants Gilead request to drop Orphan drug designation for potential Covid-19 treatment Remdesivir. https://m.firstwordpharma.com/fda-grants-gilead-request-drop-orphan-drug-designation-potential-covid-19-treatment-remdesivir
-
Covid-19 lung patterns show few clues for treating pneumonia. https://www.latimes.com/science/story/2020-03-23/covid-19-lung-patterns-pneumonia
-
utroligt der kan være sådan en forskel
-
huskede de at give zinksulfat i det kinesiske forsøg?
-
solsen, hvad mener du? Har det mindre effekt sammen med azitromycin og zink?
-
-
nå ok, det var også det jeg mente...derfor er det interessant om de kinesiske og franske studier adskiller sig på den front
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind